EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Revolutionizing MASLD: How Artificial Intelligence Is Shaping the Future of Liver Care

Nicola Pugliese iD, Arianna Bertazzoni iD, Cesare Hassan, Jörn M Schattenberg, Alessio Aghemo

Cancers · 20.02.2025 · 17 (5) · 722

DOI: 10.3390/cancers17050722 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 20.02.2025. Verfasst von Nicola Pugliese und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, MI, Italy. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is emerging as a leading cause of chronic liver disease. In recent years, artificial intelligence (AI) has attracted significant attention in healthcare, particularly in diagnostics, patient management, and drug development, demonstrating immense potential for application and implementation. In the field of MASLD, substantial research has explored the application of AI in various areas, including patient counseling, improved patient stratification, enhanced diagnostic accuracy, drug development, and prognosis prediction. However, the integration of AI in hepatology is not without challenges. Key issues include data management and privacy, algorithmic bias, and the risk of AI-generated inaccuracies, commonly referred to as “hallucinations”. This review aims to provide a comprehensive overview of the applications of AI in hepatology, with a focus on MASLD, highlighting both its transformative potential and its inherent limitations.

Schlagwörter

Stichwörter der Autor:innen

chatbotdeep machine learningfatty liver diseaseliver steatosismetabolic syndrome

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, MI, Italy.
  • Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, 20089 Rozzano, MI, Italy.
  • Endoscopy Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, 20089 Rozzano, MI, Italy.
  • Department of Internal Medicine II, Saarland University Medical Center, 66421 Homburg, Germany.

ORCID-Profile: Nicola Pugliese, Arianna Bertazzoni

Förderung

  • Italian Ministry of Health

Zitieren

APA

Pugliese, N., Bertazzoni, A., Hassan, C., Schattenberg, J. M., & Aghemo, A. (2025). Revolutionizing MASLD: How Artificial Intelligence Is Shaping the Future of Liver Care. Cancers, 17(5), 722. https://doi.org/10.3390/cancers17050722

Vancouver

Pugliese N, Bertazzoni A, Hassan C, Schattenberg JM, Aghemo A. Revolutionizing MASLD: How Artificial Intelligence Is Shaping the Future of Liver Care. Cancers. 2025;17(5):722. doi:10.3390/cancers17050722

BibTeX
@article{Pugliese2025,
  author = {Pugliese, Nicola and Bertazzoni, Arianna and Hassan, Cesare and Schattenberg, Jörn M and Aghemo, Alessio},
  title = {Revolutionizing MASLD: How Artificial Intelligence Is Shaping the Future of Liver Care},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {5},
  pages = {722},
  doi = {10.3390/cancers17050722}
}
Kostenlos starten →